关注
Luis J. Castro-Vega
Luis J. Castro-Vega
ICM - Paris Brain Institute
在 icm-institute.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
LJ Castro-Vega, A Buffet, AA De Cubas, A Cascón, M Menara, E Khalifa, ...
Human Molecular Genetics 23 (9), 2440-2446, 2013
3942013
Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism
C Lussey-Lepoutre, KER Hollinshead, C Ludwig, M Menara, A Morin, ...
Nature Communications 6, 8784, 2015
2212015
Meta-analysis of telomere length in Alzheimer’s disease
DA Forero, Y González-Giraldo, C López-Quintero, LJ Castro-Vega, ...
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2016
2152016
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
LJ Castro-Vega, E Letouzé, N Burnichon, A Buffet, PH Disderot, E Khalifa, ...
Nature Communications 6, 6044, 2015
1942015
PHACTR1 is a genetic susceptibility locus for fibromuscular dysplasia supporting its complex genetic pattern of inheritance
SR Kiando, NR Tucker, LJ Castro-Vega, A Katz, V D’Escamard, C Tréard, ...
PLoS Genetics 12 (10), e1006367, 2016
1832016
Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas.
FJ Buffet A, Morin A, Castro-Vega LJ, Habarou F, Lussey-Lepoutre C, Letouzé ...
Cancer Research, 2018
1222018
qPCR-based methods for expression analysis of miRNAs
DA Forero, Y González-Giraldo, LJ Castro-Vega, GE Barreto
Biotechniques 67 (4), 192-199, 2019
1152019
Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma.
GRAP Job S, Draskovic I, Burnichon N, Buffet A, Cros J, Lépine C, Venisse A ...
Clinical Cancer Research, 2019
982019
Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma
LB Aim, P Pigny, LJ Castro-Vega, A Buffet, L Amar, J Bertherat, D Drui, ...
Journal of medical genetics 56 (8), 513-520, 2019
732019
Rethinking pheochromocytomas and paragangliomas from a genomic perspective
LJ Castro-Vega, C Lepoutre-Lussey, AP Gimenez-Roqueplo, J Favier
Oncogene 35 (9), 1080-1089, 2016
692016
Deciphering the molecular basis of invasiveness in Sdhb-deficient cells
C Loriot, M Domingues, A Berger, M Menara, M Ruel, A Morin, ...
Oncotarget 6 (32), 32955, 2015
692015
TET-mediated hypermethylation primes SDH-deficient cells for HIF2α-driven mesenchymal transition
A Morin, J Goncalves, S Moog, LJ Castro-Vega, S Job, A Buffet, ...
Cell reports 30 (13), 4551-4566. e7, 2020
682020
Telomere length in Parkinson's disease: A meta-analysis
DA Forero, Y Gonzalez-Giraldo, C Lopez-Quintero, LJ Castro-Vega, ...
Experimental gerontology 75, 53-55, 2016
682016
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma
B Calsina, LJ Castro-Vega, R Torres-Pérez, L Inglada-Pérez, ...
Theranostics 9 (17), 4946, 2019
602019
The high expression of the microRNA 17–92 cluster and its paralogs, and the downregulation of the target gene PTEN, is associated with primary cutaneous B-cell lymphoma progression
M Battistella, M Romero, LJ Castro-Vega, G Gapihan, F Bouhidel, ...
Journal of Investigative Dermatology 135 (6), 1659-1667, 2015
512015
The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells
LJ Castro-Vega, K Jouravleva, P Ortiz-Montero, WY Liu, JL Galeano, ...
Carcinogenesis 36 (10), 1180-1192, 2015
472015
From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma
C Lepoutre-Lussey, C Thibault, A Buffet, A Morin, C Badoual, P Bénit, ...
Molecular and Cellular Endocrinology 421, 40-48, 2016
462016
Estrogen-dependent dynamic profile of eNOS-DNA associations in prostate cancer
S Nanni, A Aiello, A Re, A Guffanti, V Benvenuti, C Colussi, ...
PLoS One 8 (5), e62522, 2013
282013
Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas
LJ Castro-Vega, K Jouravleva, WY Liu, C Martinez, P Gestraud, P Hupé, ...
Carcinogenesis 34 (5), 1173-1180, 2013
272013
Emerging molecular markers of metastatic pheochromocytomas and paragangliomas
J Goncalves, C Lussey-Lepoutre, J Favier, AP Gimenez-Roqueplo, ...
Annales d'endocrinologie 80 (3), 159-162, 2019
212019
系统目前无法执行此操作,请稍后再试。
文章 1–20